- Home
- ANL vs VATE Comparison
ANL vs VATE Comparison
Compare ANL & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- VATE
- Stock Information
- Founded
- ANL 2004
- VATE 1994
- Country
- ANL Cayman Islands
- VATE United States
- Employees
- ANL N/A
- VATE N/A
- Industry
- ANL
- VATE Metal Fabrications
- Sector
- ANL
- VATE Industrials
- Exchange
- ANL Nasdaq
- VATE Nasdaq
- Market Cap
- ANL 84.5M
- VATE 82.6M
- IPO Year
- ANL 2023
- VATE 1996
- Fundamental
- Price
- ANL $2.14
- VATE $5.66
- Analyst Decision
- ANL Strong Buy
- VATE
- Analyst Count
- ANL 2
- VATE 0
- Target Price
- ANL $9.00
- VATE N/A
- AVG Volume (30 Days)
- ANL 9.6K
- VATE 49.0K
- Earning Date
- ANL 08-08-2024
- VATE 11-06-2024
- Dividend Yield
- ANL N/A
- VATE N/A
- EPS Growth
- ANL N/A
- VATE N/A
- EPS
- ANL N/A
- VATE N/A
- Revenue
- ANL $5,000,000.00
- VATE $1,231,500,000.00
- Revenue This Year
- ANL N/A
- VATE N/A
- Revenue Next Year
- ANL N/A
- VATE N/A
- P/E Ratio
- ANL N/A
- VATE N/A
- Revenue Growth
- ANL N/A
- VATE N/A
- 52 Week Low
- ANL $1.85
- VATE $3.25
- 52 Week High
- ANL $17.48
- VATE $13.00
- Technical
- Relative Strength Index (RSI)
- ANL 43.45
- VATE 51.57
- Support Level
- ANL $2.23
- VATE $5.43
- Resistance Level
- ANL $2.44
- VATE $6.48
- Average True Range (ATR)
- ANL 0.19
- VATE 0.43
- MACD
- ANL -0.01
- VATE -0.05
- Stochastic Oscillator
- ANL 23.43
- VATE 22.94
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.